Arcus Biosciences, Inc.

RCUS Net buying

CIK 0001724521 #1577 in the set updated 17 Sep 2026

Bought (120 mo)

$581.93M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$27.20M

$17.32M on a plan · $1.84M straight out of an exercise

Sold at will

$8.04M

85 of 151 sales

Net

+$554.73M

+$573.89M against sales at will

By person

22 insiders · 202 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

GILEAD SCIENCES, INC. entity

10% owner

$574.80M (4)

—

+$574.80M

31,424,760

24.68%

$942.74M

+285.0%

Jarrett Jennifer

Chief Operating Officer

—

$11.77M (44) scheduled

−$11.77M

224,024

0.1759%

$6.72M

+114.5%

Jaen Juan C.

President

$1.43M (8)

$10.34M (38) scheduled

−$8.91M

2,771,492

2.18%

$83.14M

+23.0%

FALBERG KATHRYN E

Director

$1.55M (7)

—

+$1.55M

146,406

0.1150%

$4.39M

+614.0%

ROSEN TERRY J

Chief Executive Officer

$3.70M (23)

$2.22M (16) scheduled

+$1.49M

14,350,965

11.27%

$430.53M

+21.7%

Goeltz II Robert C.

Chief Financial Officer

$107.85K (1)

$1.15M (17) scheduled

−$1.04M

84,161

0.0661%

$2.52M

+11,923%

Tang Carolyn C.

General Counsel

—

$572.90K (16) scheduled

−$572.90K

184,607

0.1450%

$5.54M

+265.9%

Azoy Alexander

Chief Accounting Officer

—

$499.62K (12) scheduled

−$499.62K

39,581

0.0311%

$1.19M

+112.9%

Grossman William

Chief Medical Officer

$7.14K (4)

$439.34K (6)

−$432.19K

20,723

0.0163%

$621.69K

—

KANEKO YASUNORI

Director

$330.85K (2)

—

+$330.85K

919,355

0.7220%

$27.58M

+3,648%

Markus Richard

Chief Medical Officer

—

$210.14K (2) scheduled

−$210.14K

89,647

0.0704%

$2.69M

—

GV 2016 GP, L.L.C.

10% owner

—

—

—

3,125,312

2.45%

$93.76M

—

GV 2017 GP, L.L.C.

10% owner

—

—

—

1,924,474

1.51%

$57.73M

—

Hadley Harbor Master Investors (Cayman) II L.P.

10% owner

—

—

—

1,496,813

1.18%

$44.90M

—

COLUMN GROUP II, LP entity

10% owner

—

—

—

470,427

0.3694%

$14.11M

—

Nuyten Dimitry SA

Chief Medical Officer

—

—

—

87,518

0.0687%

$2.63M

+2,804%

Lacey David L.

Director

—

—

—

76,652

0.0602%

$2.30M

+116.8%

Ribas Antoni

Director

—

—

—

52,853

0.0415%

$1.59M

+288.5%

PERLMAN ANDREW J

Director

—

—

—

48,325

0.0380%

$1.45M

+1,814%

Machado Patrick

Director

—

—

—

44,300

0.0348%

$1.33M

—

Lambert Nicole

Director

—

—

—

43,000

0.0338%

$1.29M

—

Barker Jason

See Remarks

—

—

—

10,000

0.0079%

$300.00K

—

Individual transactions

2

Insider

Date

Role

Action

Shares

Price

Amount

Tang Carolyn C.

11 Jun 2026

General Counsel

Exercised, kept

34,090

$2.57

$87.75K

KANEKO YASUNORI

5 Jun 2020

Director

Exercised, kept

35,000

$7.99

$279.65K

Show all 202 transactions →

What was left out

Form 4 filings counted 258

Amendments (4/A) skipped 1

Filings about a different issuer 0

Unreadable filings 0

Joint filings 3

Sales on a Rule 10b5-1 plan 61

Sales straight out of an exercise 5

Sales at will 85

Transactions with no price 0

Shares from compensation/vesting 20,866,287

Sales filed before the plan box existed 84

History held since 19 Mar 2018